CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Clinical efficacy of adalimumab versus infliximab and the factors associated with recurrence or aggravation during treatment of anal fistulas in Crohn's disease
Cheng-Chun Ji, Shota Takano
Intest Res. 2017;15(2):182-186.   Published online April 27, 2017
DOI: https://doi.org/10.5217/ir.2017.15.2.182

Excel Download

Clinical efficacy of adalimumab versus infliximab and the factors associated with recurrence or aggravation during treatment of anal fistulas in Crohn's disease
Intestinal Research. 2017;15(2):182   Crossref logo
Link1 Link2 Link3

Adalimumab/etanercept/infliximab
Reactions Weekly. 2015;1556(1):21-21   Crossref logo
Link1 Link2 Link3

A retrospective comparison of infliximab versus adalimumab as induction and maintenance therapy for Crohn disease
Internal Medicine Journal. 2016;46(7):798-804   Crossref logo
Link1

Adalimumab treatment in Crohn's disease: an overview of long-term efficacy and safety in light of the EXTEND trial
Clinical and Experimental Gastroenterology. 2013;153   Crossref logo
Link1

Plasma trough levels of adalimumab and infliximab in terms of clinical efficacy during the treatment of psoriasis
The Journal of Dermatology. 2012;40(1):39-42   Crossref logo
Link1

Comparison between infliximab and adalimumab in the treatment of perianal fistulas in Crohn's disease
Journal of Coloproctology. 2014;34(3):154-158   Crossref logo
Link1 Link2

Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn’s disease
Biologics: Targets and Therapy. 2018;Volume 12:69-73   Crossref logo
Link1 Link2

W1211 On Demand Treatment of Crohn's Disease Patients With Infliximab is Associated With Increased Need for Later Treatment With Adalimumab
Gastroenterology. 2010;138(5):S-675   Crossref logo
Link1 Link2

Long-term efficacy of adalimumab in the treatment of uveitis associated with juvenile idiopathic arthritis
Clinical Ophthalmology. 2011;1425   Crossref logo
Link1

Cost-Minimization analysis of Infliximab versus Adalimumab in the treatment of Crohn’s disease and Ulcerative Colitis
Value in Health. 2015;18(3):A296   Crossref logo
Link1 Link2